Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions

Clinical and Experimental Dermatology

Volumn 35, Issue 8, 2010, Pages 863-868

  Hirahara, K ^a   Kano, Y ^a   Mitsuyama, Y ^a   Takahashi, R ^b   Kimishima, M ^a   Shiohara, T ^b  

^a Department of Dermatology ^*  (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALLOPURINOL; AMOXICILLIN; BUCOLOME; CARBAMAZEPINE; CORTICOSTEROID; DAPSONE; DICLOFENAC; GAMMA INTERFERON; HEPATITIS B ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MEXILETINE; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; ZONISAMIDE;

ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; DRESS SYNDROME; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; FEMALE; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; TREATMENT DURATION; VIRUS INFECTION; VIRUS REACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; DNA VIRUSES; DRUG ERUPTIONS; EOSINOPHILIA; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; IMMUNOGLOBULINS; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA VIRUSES; STEVENS-JOHNSON SYNDROME;

EID: 78149371703     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2010.03820.x     Document Type: Article

References (24)

1. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995; 155: 2285-90.
2. Aihara M, Sugita Y, Takahashi S et al. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol 2001; 144: 1231-4.
3. Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003; 3: 255-60.
4. Kano Y, Inaoaka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6: reactivation and hypogammaglobulinemia. Arch Dermatol 2004; 140: 183-8.
5. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-85.
6. Roujeau JC. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123-9.
7. Hung SI, Chung WH, Liou LB et al. HLA-B*5810 allele as a genetic marker for the severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134-9.
8. Chung WH, Hung SI, Chen YT. Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 2007; 7: 317-23.
9. Kano Y, Hirahara K, Sakuma K, Shiohara T. Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease. Br J Dermatol 2006; 155: 301-6.
10. Shiohara T, Takahashi R, Kano Y. Drug-induced hypersensitivity syndrome and viral reactivation. In: Drug Hypersensitivity (Pichler WJ, ed). Basel: Karger Press, 2007; 251-66.
11. Bastuji-Garin S, Rzany B, Stern RS et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-6.
12. Shiohara T, Iijima M, Ikazawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol 2007; 156: 1083-4.
13. Kano Y, Hirahara K, Mitsuyama Y et al. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 2007; 62: 1439-44.
14. + T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol 2006; 176: 7736-44.
15. Hasannejad H, Takahashi R, Kimishima M et al. Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis. J Allergy Clin Immunol 2007; 120: 69-75.
16. Carson R, Vigbali D. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999; 277: 41-52.
17. Cook EB, Stahl JL, Lowe L et al. Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics. J Immunol Meth 2001; 254: 109-18.
18. Caproni M, Torchia D, Schincaglia E et al. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br J Dermatol 2006; 155: 722-8.
19. Choquet-Kastylevsky G, Intrator L, Chenal C et al. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol 1998; 139: 1026-32.
20. Yamaguchi K. Human T-lymphotropic virus type in Japan. Lancet 1994; 343: 213-16.
21. Ahmad REI, Bassam S, Cordeiro P, Menezes J. Requirement of TLR-mediated signaling for the induction of IL-15 gene expression in human monocytic cells by HSV-1. Blood 2008; 112: 2360-8.
22. + T cells in vivo by IL-15. Immunity 1998; 8: 591-9.
23. Shiohara T, Mizukawa Y, Takahashi R, Kano Y. Pathomechanisms of lichen planus autoimmunity elicited by cross-reactive T cells. Curr Dir Autoimmun 2008; 10: 206-26.
24. Gerber BO, Pichler WJ. The p-i concept: evidence and implications. In: Drug Hypersensitivity (Pichler WJ, ed). Basel: Karger Press, 2007; 66-73.